Expert Review of VaccinesIntroduction Routine meningococcal vaccination campaigns have substantially reduced the burden of invasive meningococcal disease in pediatric individuals, leading to relative increases in burden in older age groups.
Olga Syrkina +4 more
doaj +1 more source
Bioinformatics Analysis of Global Diversity in Meningococcal Vaccine Antigens over the Past 10 Years: Vaccine Efficacy Prognosis. [PDF]
Med Sci (Basel), 2023 Savitskaya VY +7 more
europepmc +1 more source
Brazilian Journal of Infectious DiseasesIntroduction: Meningitis is a communicable infectious disease with a significant disease burden and possible unfavorable outcomes. In this context, the World Health Organization (WHO) and the Pan American Health Organization (PAHO) developed the roadmap “
Nathália Amaro Schmidt +1 more
doaj +1 more source
Evaluating vaccine-elicited antibody activities against <i>Neisseria gonorrhoeae</i>: cross-protective responses elicited by the 4CMenB meningococcal vaccine. [PDF]
Infect Immun, 2023 Gray MC +6 more
europepmc +1 more source
Meningococcal ACWY vaccine [PDF]
Meningococcal disease is a serious illness caused by a type of bacteria called Neisseria meningitidis. It can lead to meningitis (infection of the lining of the brain and spinal cord) and infections of the blood.
core
Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial. [PDF]
Hum Vaccin Immunother, 2022 Knuf M +7 more
europepmc +1 more source
Exploiting Real-Time Genomic Surveillance Data To Assess 4CMenB Meningococcal Vaccine Performance in Scotland, 2015 to 2022. [PDF]
mBio, 2023 Rodrigues CMC +5 more
europepmc +1 more source